Cargando…

Quality of life and acquired organ damage are intimately related to activity limitations in patients with systemic lupus erythematosus

BACKGROUND: Systemic lupus erythematosus (SLE) is an autoimmune multi-organ disease, characterized by episodes of disease flares and remissions over time, which may restrain affected patients’ ability to perform daily activities. The purpose of the present study was to characterize variation in acti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Björk, Mathilda, Dahlström, Örjan, Wetterö, Jonas, Sjöwall, Christopher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531389/ https://www.ncbi.nlm.nih.gov/pubmed/26264937 http://dx.doi.org/10.1186/s12891-015-0621-3

Ejemplares similares

The majority of Swedish systemic lupus erythematosus patients are still affected by irreversible organ impairment: factors related to damage accrual in two regional cohorts
por: Frodlund, M, et al.
Publicado: (2019)

Application of the 2012 Systemic Lupus International Collaborating Clinics classification criteria to patients in a regional Swedish systemic lupus erythematosus register
por: Ighe, Anna, et al.
Publicado: (2015)

The Complex Role of C-Reactive Protein in Systemic Lupus Erythematosus
por: Enocsson, Helena, et al.
Publicado: (2021)

Limited Association between Antibodies to Oxidized Low-Density Lipoprotein and Vascular Affection in Patients with Established Systemic Lupus Erythematosus
por: Wirestam, Lina, et al.
Publicado: (2023)

Associations of C-reactive protein isoforms with systemic lupus erythematosus phenotypes and disease activity
por: Karlsson, Jesper, et al.
Publicado: (2022)

Associations between antinuclear antibody staining patterns and clinical features of systemic lupus erythematosus: analysis of a regional Swedish register
por: Frodlund, Martina, et al.
Publicado: (2013)

Plasma osteopontin versus intima media thickness of the common carotid arteries in well-characterised patients with systemic lupus erythematosus
por: Wirestam, Lina, et al.
Publicado: (2021)

Relationship between remission, disease activity and patient-reported outcome measures in patients with recent-onset systemic lupus erythematosus
por: Heijke, Rebecca, et al.
Publicado: (2020)

Comparing longitudinal patient-reported outcome measures between Swedish patients with recent-onset systemic lupus erythematosus and early rheumatoid arthritis
por: Heijke, Rebecca, et al.
Publicado: (2021)

The diagnostic accuracies of the 2012 SLICC criteria and the proposed EULAR/ACR criteria for systemic lupus erythematosus classification are comparable
por: Dahlström, Ö, et al.
Publicado: (2019)

Usefulness of Clinical and Laboratory Criteria for Diagnosing Autoimmune Liver Disease among Patients with Systemic Lupus Erythematosus: An Observational Study
por: Heijke, Rebecca, et al.
Publicado: (2021)

C-Reactive Protein Levels in Systemic Lupus Erythematosus Are Modulated by the Interferon Gene Signature and CRP Gene Polymorphism rs1205
por: Enocsson, Helena, et al.
Publicado: (2021)

Comparison of Surrogate Markers of the Type I Interferon Response and Their Ability to Mirror Disease Activity in Systemic Lupus Erythematosus
por: Enocsson, Helena, et al.
Publicado: (2021)

Doubtful Clinical Value of Subtyping Anti-U1-RNP Antibodies Regarding the RNP-70 kDa Antigen in Sera of Patients with Systemic Lupus Erythematosus
por: Ahmad, Awais, et al.
Publicado: (2023)

Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus
por: Wirestam, Lina, et al.
Publicado: (2015)

Serum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritis
por: Sjöwall, Christopher, et al.
Publicado: (2009)

Impact of Belimumab on Organ Damage in Systemic Lupus Erythematosus
por: Urowitz, Murray B., et al.
Publicado: (2022)

Quality of Life in Systemic Lupus Erythematosus
por: Panopalis, Pantelis, et al.
Publicado: (2006)

Sphingolipids and Diagnosis, Prognosis, and Organ Damage in Systemic Lupus Erythematosus
por: Harden, Olivia C., et al.
Publicado: (2020)

NET Formation in Systemic Lupus Erythematosus: Changes during the COVID-19 Pandemic
por: Knopf, Jasmin, et al.
Publicado: (2022)

Clinical Experience of Sirolimus Regarding Efficacy and Safety in Systemic Lupus Erythematosus
por: Eriksson, Per, et al.
Publicado: (2019)

Evaluation of Thrombocytopenia in Systemic Lupus Erythematosus and Correlation with Different Organs Damages
por: Ktona, Ergeta, et al.
Publicado: (2014)

Osteoporosis in Systemic Lupus Erythematosus - Correlations with Disease Activity and Organ Damage
por: BARBULESCU, A., et al.
Publicado: (2015)

Quality of life in systemic lupus erythematosus and its measurement
por: Olesińska, Marzena, et al.
Publicado: (2018)

Quality of Life of Pregnant Women with Systemic Lupus Erythematosus
por: Rodrigues, Larissa, et al.
Publicado: (2022)

Clinical Heterogeneity, Unmet Needs and Long-Term Outcomes in Patients with Systemic Lupus Erythematosus
por: Sjöwall, Christopher, et al.
Publicado: (2022)

B Cell Therapy in Systemic Lupus Erythematosus: From Rationale to Clinical Practice
por: Parodis, Ioannis, et al.
Publicado: (2020)

B cells in systemic lupus erythematosus: Targets of new therapies and surveillance tools
por: Parodis, Ioannis, et al.
Publicado: (2022)

Acquired Von Willebrand's Syndrome in Systemic Lupus Erythematosus
por: Taveras Alam, Sara, et al.
Publicado: (2014)

Systemic Lupus Erythematosus Patients With Related Organic Damage Are at High Risk of Hypothyroidism
por: Ni, Jiajia, et al.
Publicado: (2022)

Domains and Determinants of Quality of Life in Schizophrenia and Systemic Lupus Erythematosus
por: Radhakrishnan, Rajiv, et al.
Publicado: (2012)

Neuropsychiatric symptoms in systemic lupus erythematosus: impact on quality of life
por: Monahan, R C, et al.
Publicado: (2017)

Depression, anxiety, and quality of life in patients with systemic lupus erythematosus
por: Dehghan, Ali, et al.
Publicado: (2023)

Contributions of de novo variants to systemic lupus erythematosus
por: Almlöf, Jonas Carlsson, et al.
Publicado: (2020)

Plasma C-Reactive Protein and Pentraxin-3 Reference Intervals During Normal Pregnancy
por: Wirestam, Lina, et al.
Publicado: (2021)

Serum levels of soluble urokinase plasminogen activator receptor in juvenile idiopathic arthritis: a single-center Swedish case-control study
por: Lewander, Per, et al.
Publicado: (2023)

Serum protein pattern associated with organ damage and lupus nephritis in systemic lupus erythematosus revealed by PEA immunoassay
por: Petrackova, Anna, et al.
Publicado: (2017)

Shared and Unique Patterns of DNA Methylation in Systemic Lupus Erythematosus and Primary Sjögren's Syndrome
por: Imgenberg-Kreuz, Juliana, et al.
Publicado: (2019)

Long-term safety and limited organ damage in patients with systemic lupus erythematosus treated with belimumab: a Phase III study extension
por: van Vollenhoven, Ronald F, et al.
Publicado: (2020)

Plasma osteopontin as a marker for future organ damage in pediatric systemic lupus erythematosus
por: Rullo, Ornella J, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4urtvja4es0viuj4riq8u1d36u